B. Riley Financial Announces the $117.8 Million Sale of GlassRatner to TorQuest Partners

Stock Information for Cellectar Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cellectar Biosciences Inc.

B. Riley Receives Expected Nasdaq Delinquency Notification; Anticipates Meeting New Filing Deadlines
B. Riley Financial Reports First Quarter 2025 Results
B. Riley Financial Announces Corporate Name Change to BRC Group Holdings, Inc.
B. Riley Financial Receives Nasdaq Staff Determination Letter; Will Seek Hearing & Continued Listing
B. Riley Financial Hires BDO USA for 2025 Audit
B. Riley Financial Announces Notification of Delinquency with Nasdaq
B. Riley Financial Shares Preliminary Fourth Quarter and Full Year 2024 Results and Financial Estimates and Business Update for First Half 2025
B. Riley Securities Provides Post-Carve Out Business Update and Financial Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.